SynthesisFrontiers in public health2026
Smoking prevalence and emerging tobacco product use among Saudi adolescents: a systematic review.
Synthesis in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To synthesize updated prevalence findings on tobacco and emerging nicotine product use, such as e-cigarettes, among Saudi adolescents based on evidence published since 2018 and to summarize reported sociodemographic and behavioral factors associated with use. Methods: A systematic review was conducted following the PRISMA 2020 guidelines. We searched PubMed, Embase, Scopus, and Web of Science for observational studies published between March 2018 and February 2026. This timeframe was chosen to update the review, which included studies published up to March 2018, and to incorporate evidence generated during the healthcare reforms introduced under Saudi Vision 2030. Study selection and data extraction were conducted using predefined eligibility criteria and standardized extraction forms. Eligible studies included Saudi adolescents aged 10-19 years reporting prevalence rates of cigarette smoking, waterpipe use, electronic cigarettes, or other nicotine products. The risk of bias was assessed using the Joanna Briggs Institute (JBI) critical appraisal checklist for cross-sectional studies. A narrative synthesis was performed. Results: Twelve studies reporting the prevalence of smoking among adolescents in Saudi Arabia were included. The prevalence of current cigarette smoking ranged from 2.8% in nationally representative surveys to 40.8% in male-only regional samples. Most mixed-gender, school-based studies reported current smoking prevalence between 8 and 23%, while ever-smoking prevalence exceeded 40% in some male-only studies. Emerging tobacco products were widely used, with e-cigarette prevalence ranging from 3 to 20.6%, and shisha use reported as high as 29%. Patterns of dual and poly-tobacco use, particularly involving e-cigarettes and hookah, were common. Across studies, males consistently demonstrated higher smoking prevalence than females. Peer smoking and family smoking were the factors most consistently associated with tobacco use across studies. Conclusion: Tobacco use among Saudi adolescents remains prevalent and varies across regions, with reported use of electronic cigarettes and dual-use patterns. Tailored prevention strategies are needed to address smoking behaviors in Saudi adolescents. National studies should be conducted to better estimate tobacco products use and other addictive behaviors among youth, guiding future prevention efforts. Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420261320020, identifier (CRD420261320020).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.